Evidence map›Paper›PMID 36099708›Full record

ArticleEpidemics2022

Impact of spatiotemporal heterogeneity in COVID-19 disease surveillance on epidemiological parameters and case growth rates.

Rhys P D Inward, Felix Jackson, Abhishek Dasgupta, Graham Lee, Anya Lindström Battle, Kris V Parag, Moritz U G Kraemer, Global.health consortium

Abstract read
In one paragraph

Article in Epidemics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rhys P D InwardDepartment of Biology, University of Oxford, United Kingdom. Electronic address: rhys.inward@zoo.ox.ac.uk.
Felix JacksonDepartment of Biology, University of Oxford, United Kingdom; Department of Computer Science, University of Oxford, United Kingdom.
Abhishek DasguptaDepartment of Biology, University of Oxford, United Kingdom; Department of Computer Science, University of Oxford, United Kingdom.
Graham LeeDepartment of Biology, University of Oxford, United Kingdom; Department of Computer Science, University of Oxford, United Kingdom.
Anya Lindström BattleDepartment of Biology, University of Oxford, United Kingdom.
Kris V ParagMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom; NIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, United Kingdom.
Moritz U G KraemerDepartment of Biology, University of Oxford, United Kingdom; Reuben College, University of Oxford, United Kingdom. Electronic address: moritz.kraemer@zoo.ox.ac.uk.
Global.health consortium

Funding

Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

SARS-CoV-2 case data are primary sources for estimating epidemiological parameters and for modelling the dynamics of outbreaks. Understanding biases within case-based data sources used in epidemiological analyses is important as they can detract from the value of these rich datasets. This raises questions of how variations in surveillance can affect the estimation of epidemiological parameters such as the case growth rates. We use standardised line list data of COVID-19 from Argentina, Brazil, Mexico and Colombia to estimate delay distributions of symptom-onset-to-confirmation, -hospitalisation and -death as well as hospitalisation-to-death at high spatial resolutions and throughout time. Using these estimates, we model the biases introduced by the delay from symptom-onset-to-confirmation on national and state level case growth rates (rt) using an adaptation of the Richardson-Lucy deconvolution algorithm. We find significant heterogeneities in the estimation of delay distributions through time and space with delay difference of up to 19 days between epochs at the state level. Further, we find that by changing the spatial scale, estimates of case growth rate can vary by up to 0.13 d

Indexed as

COVID-19BrazilDisease OutbreaksHospitalizationHumansSARS-CoV-2Epidemic modelsOutbreak surveillanceSARS-CoV-2

Identifiers

PMID36099708
PMCPMC9443927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.